Results 281 to 290 of about 143,948 (293)
Some of the next articles are maybe not open access.
BJU International, 2020
To provide an update on novel minimally invasive lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) treatments in a non‐systematic review.
S. Madersbacher, C. Roehrborn, M. Oelke
semanticscholar +1 more source
To provide an update on novel minimally invasive lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) treatments in a non‐systematic review.
S. Madersbacher, C. Roehrborn, M. Oelke
semanticscholar +1 more source
BJU International, 2019
To present 6‐month safety and effectiveness data from a multicentre prospective study of aquablation in men with lower urinary tract symptoms (LUTS) attributable to benign prostatic hyperplasia (BPH) with prostate volumes between 80 and 150 mL.
M. Desai+23 more
semanticscholar +1 more source
To present 6‐month safety and effectiveness data from a multicentre prospective study of aquablation in men with lower urinary tract symptoms (LUTS) attributable to benign prostatic hyperplasia (BPH) with prostate volumes between 80 and 150 mL.
M. Desai+23 more
semanticscholar +1 more source
BJU International, 2019
To assess the quality of videos on the surgical treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) available on YouTube, given that such video‐sharing platforms are frequently used as sources of patient ...
P. Betschart+8 more
semanticscholar +1 more source
To assess the quality of videos on the surgical treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) available on YouTube, given that such video‐sharing platforms are frequently used as sources of patient ...
P. Betschart+8 more
semanticscholar +1 more source
Tadalafil for the treatment of benign prostatic hyperplasia
Expert Opinion on Pharmacotherapy, 2019Introduction: In men, lower urinary tract symptoms (LUTS) are primarily attributed to benign prostatic hyperplasia (BPH). Therapeutic options are targeted to relax prostate smooth muscle and/or reduce prostate enlargement.
F. Mónica, G. De Nucci
semanticscholar +1 more source
‘En Bloc’ HoLEP with early apical release in men with benign prostatic hyperplasia
World journal of urology, 2019G. Saitta+6 more
semanticscholar +1 more source
The development of human benign prostatic hyperplasia with age.
Journal of Urology, 1984S. Berry+3 more
semanticscholar +1 more source